Nonsustained ventricular tachycardia: identification and management of high-risk patients. (Q40821309)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

review article

1 reference

title

Nonsustained ventricular tachycardia: identification and management of high-risk patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

main subject

ventricular tachycardia

1 reference

L A Pires

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

S K Huang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

language of work or name

English

0 references

publication date

1 July 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

189-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

Sudden coronary death in the United States: 1980-1985

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prevalence, characteristics and significance of ventricular premature complexes and ventricular tachycardia detected by 24-hour continuous electrocardiographic recording in the Cardiac Arrhythmia Suppression Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Long-term follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular Premature Beats and Mortality after Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular arrhythmias in aortic valve disease: analysis of 102 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Clinical classification of cardiac deaths

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

How the university cardiologist treats ventricular premature beats: a nationwide survey of 65 University Medical Centers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Treatment of ventricular arrhythmias by United States cardiologists: a survey before the cardiac arrhythmia suppression trial results were available

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular ectopic beats and their relation to sudden and nonsudden cardiac death after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Risk factors for sudden death after acute myocardial infarction: two-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Relationship between clinical features of acute myocardial infarction and ventricular runs 2 weeks to 1 year after infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular Arrhythmias 3 Weeks After Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Paroxysmal ventricular tachycardia during repeated 24-hour ambulatory electrocardiographic monitoring of postmyocardial infarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Use of ambulatory electrocardiographic (Holter) monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Silent myocardial ischemia. Clinical significance and relation to sudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Correlation between the signal-averaged electrocardiogram from Holter tapes and from real-time recordings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Spontaneous variability of complex ventricular arrhythmias detected by long-term electrocardiographic recording

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Spontaneous variability of ventricular arrhythmias in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The natural history of benign and potentially malignant ventricular arrhythmias with special reference to nonsustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Avoiding interpretive pitfalls when assessing arrhythmia suppression after myocardial infarction: Insights from the long-term observations of the placebo-treated patients in the Cardiac Arrhythmia Pilot Study (CAPS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The prognostic value of exercise capacity: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic value of ventricular arrhythmias associated with treadmill exercise testing in patients studied with cardiac catheterization for suspected ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular arrhythmias during exercise testing: mechanism, response to coronary bypass surgery and prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The prognostic significance of serial exercise testing after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Assessment of hemodynamic significance of isolated stenoses of the left anterior descending coronary artery using thallium-201 myocardial scintigraphy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Determinants of prognosis in survivors of myocardial infarction: a prospective clinical angiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Multivessel coronary artery disease: a key predictor of short-term prognosis after reperfusion therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Risk stratification in survivors of acute myocardial infarction: routine cardiac catheterization and angiography is a reasonable approach in most patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Risk stratification and survival after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Influence of ventricular function and presence or absence of coronary artery disease on results of electrophysiologic testing for asymptomatic nonsustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Value of electrophysiologic testing in patients with nonsustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Programmed electrical stimulation and long-term follow-up in asymptomatic, nonsustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Value of electrophysiologic testing in patients with previous myocardial infarction and nonsustained ventricular tachycardia. Philadelphia Arrhythmia Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Nonsustained ventricular tachycardia in patients with coronary artery disease: role of electrophysiologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effect of left ventricular aneurysm on risk of sudden and nonsudden cardiac death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Late potentials detected after myocardial infarction: natural history and prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Predicting arrhythmic events after acute myocardial infarction using the signal-averaged electrocardiogram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation in nonsustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Role of signal averaging of the surface QRS complex in selecting patients with nonsustained ventricular tachycardia and high grade ventricular arrhythmias for programmed ventricular stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The signal-averaged electrocardiogram as a screening test for inducibility of sustained ventricular tachycardia in high risk patients: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Time course of moricizine's effect on signal-averaged and 12 lead electrocardiograms: Insights into mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Oral amiodarone loading therapy. I. The effect on serial signal-averaged electrocardiographic recordings and the QTc in patients with ventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic significance of the signal-averaged ECG depends on the time of recording in the postinfarction period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

A randomized clinical trial of the noninvasive and invasive approaches to drug therapy of ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Out-of-hospital cardiac arrest: electrophysiologic observations and selection of long-term antiarrhythmic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrophysiological testing and nonsustained ventricular tachycardia. Use and limitations in patients with coronary artery disease and impaired ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Value of programmed ventricular stimulation in the evaluation and management of patients with nonsustained ventricular tachycardia associated with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Use of electrophysiologic testing in patients with nonsustained ventricular tachycardia: prognostic and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Programmed electrical stimulation to determine the need for antiarrhythmic therapy in patients with complex ventricular ectopic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Decline in inducibility of sustained ventricular tachycardia from two to twenty weeks after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Usefulness of early versus late programmed ventricular stimulation in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The approach to nonsustained ventricular tachycardia after a myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Identifying patients for prophylactic automatic implantable cardioverter defibrillator therapy: Status of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effect of propranolol in patients with myocardial infarction and ventricular arrhythmia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Antiarrhythmics and VPD suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Side effects from amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Dilated cardiomyopathies of the adult (second of two parts).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Sudden unexpected death in patients with congestive heart failure: a second frontier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: Observations in 35 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Factors influencing the one-year mortality of dilated cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Long-term prognostic significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Diverse mechanisms of unexpected cardiac arrest in advanced heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Occurrence and clinical significance of endocardial late potentials and fractionations in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Noninvasive detection of patients with ischemic and nonischemic heart disease prone to ventricular fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Abnormal signal-averaged electrocardiograms in patients with nonischemic congestive cardiomyopathy: relationship to sustained ventricular tachyarrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy: influence of the underlying heart disease on the results of electrophysiologic testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The response of patients with complex ventricular arrhythmias secondary to dilated cardiomyopathy to programmed electrical stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic role of inducible ventricular tachycardia in patients with dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Idiopathic dilated cardiomyopathy. Role of programmed electrical stimulation and Holter monitoring in predicting those at risk of sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Relative efficacy of vasodilator therapy in chronic congestive heart failure. Implications of randomized trials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

ACE inhibitors--a cornerstone of the treatment of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Beta blockade for dilated cardiomyopathy: the evidence against therapeutic benefit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Pharmacology, pharmacodynamics and pharmacokinetics of sotalol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prospective, double-blind, placebo-controlled trial of low-dose amiodarone in patients with severe heart failure and asymptomatic frequent ventricular ectopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Arrhythmia in hypertrophic cardiomyopathy. I: Influence on prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Relation between extent of left ventricular hypertrophy and occurrence of ventricular tachycardia in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Signal-averaged electrocardiography in hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The prevalence of arrhythmias in hypertrophic cardiomyopathy: role of ambulatory monitoring and signal-averaged electrocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Amiodarone for long-term management of patients with hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

A review of rhythm disorders in cardiac hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Left ventricular hypertrophy: Diagnosis, prognosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Ventricular arrhythmia in untreated newly presenting hypertensive patients compared with matched normal population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Left ventricular hypertrophy: impact of calcium channel blocker therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Late potentials in mitral valve prolapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Programmed ventricular stimulation in mitral valve prolapse: analysis of 36 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

The yield of programmed ventricular stimulation in mitral valve prolapse patients with ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Complex ventricular arrhythmias associated with the mitral valve prolapse syndrome. Effectiveness of moricizine (Ethmozine) in patients resistant to conventional antiarrhythmics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrophysiologic studies during acute myocardial infarction: do they prognosticate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Reduction in the frequency of ventricular late potentials after acute myocardial infarction by early thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Decreased incidence of ventricular late potentials after successful thrombolytic therapy for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: a prospective, randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Electrically induced ventricular arrhythmias in acute myocardial infarction treated with thrombolytic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

Sudden death in hypertrophic and dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2807%2980028-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-8703(07)80028-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8322664%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference